Výsledky vyhledávání - "Fritha J. Hanning"

A case of large cell neuroendocrine carcinoma of the bladder with prolonged spontaneous remission

Autor: Jonathan Zwi, Jon Cadwallader, Andrew K. Williams, Remy Lim, Vincent Chong, Fritha J. Hanning

Publikováno v: Journal of Surgical Case Reports

Large cell neuroendocrine carcinoma (LCNEC) of the urinary bladder are rare. We present a case of a 72-year-old man who presented with back pain and acute renal failure. Ultrasound showed a soft tissue mass in the base of the bladder causing bilatera

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c42bb71c26478cdf75544717e1fcb48
https://doi.org/10.1093/jscr/rjw179

Zobrazit plný text záznamu

Testosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort study

Autor: Martin R. Stockler, Amy L. Boland, Damien Thomson, Peter Grimison, A. McDonald, New Zealand Urogenital, N. Singhal, Guy C. Toner, Brent O'Carrigan, C. Underhill, Fritha J. Hanning, Ian D. Davis, Hayley S. Whitford, P. Clingan, Ian N. Olver, M. Fournier

Publikováno v: Internal Medicine Journal. 44:813-817

This is the first prospective study in a contemporary Australian/New Zealand population to determine the prevalence of testosterone deficiency in testicular cancer survivors at 12 months from treatment, and any association with poorer quality of life

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7a4e448fd975cf1aa0d5c70c977835d6
https://doi.org/10.1111/imj.12500

Zobrazit plný text záznamu

Real world experience of docetaxel in elderly patients with advanced prostate cancer

Autor: Fritha J. Hanning, Peter C.C. Fong, Paula Barlow, Simon Yuen Fai Fu, Carmel Maree Jacobs

Publikováno v: Journal of Clinical Oncology. 36:313-313

313 Background: Docetaxel (D) chemotherapy is a standard of care in men with advanced prostate cancer (APC), both metastatic castration sensitive (CS) and castration resistant (CR) disease. The risk of significant toxicities may deter D use in elderl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0730e75b8a93aa05d3934079e7e127f1
https://doi.org/10.1200/jco.2018.36.6_suppl.313

Zobrazit plný text záznamu

Everolimus and zoledronic acid in patients with renal cell carcinoma with bone metastases: a randomized first-line phase II trial

Autor: Michael Findlay, Peter C.C. Fong, Richard T. North, Reuben James Broom, Stephanie Pollard, Garry Forgeson, Sanjeev Deva, Anne O'Donnell, Janie Proctor, D. Harris, Victoria Hinder, Andrew Grey, Michael B. Jameson, Fritha J. Hanning, Katrina Sharples, Steven Duffey

Publikováno v: Clinical genitourinary cancer. 13(1)

Bone metastases from renal cell carcinoma (RCC) are a major cause of morbidity. Post hoc analysis has suggested that bone turnover markers can identify patients at risk of skeletal-related events (SREs) among those receiving zoledronic acid. This stu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::313b6cead07771393ca669310b095c36
https://pubmed.ncbi.nlm.nih.gov/25163397

Zobrazit plný text záznamu

Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability

Autor: Paul Thompson, Michael Findlay, Andrew G. Hill, Mark J. McKeage, Dragan Damianovich, Fritha J. Hanning, Peter S. Bergin

Publikováno v: BMC Cancer, Vol 10, Iss 1, p 451 (2010)
BMC Cancer

Background Platinum-based drugs, such as cisplatin and oxaliplatin, are well-known for inducing chronic sensory neuropathies but their acute and motor neurotoxicities are less well characterised. Use was made of nerve conduction studies and needle el

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b12a7b2305c2d979c779d649a5b840d4
http://www.biomedcentral.com/1471-2407/10/451

Zobrazit plný text záznamu

Cardiac effects of Dovitinib in first-line metastatic renal cell carcinoma: Sub-analysis of a phase II clinical trial

Autor: Robert N. Doughty, Reuben James Broom, Steven Duffey, Fritha J. Hanning, Michael Kuan-Ching Lee, Christine Crooks, Kerin Thompson, Peter C.C. Fong, Georgia Wilson, Mark J. McKeage

Publikováno v: Journal of Clinical Oncology. 33:e15605-e15605

e15605 Background: Dovitinib is an anti-VEGFR tyrosine kinase inhibitor (TKI) which also inhibits FGFR-1,-2,-3 and PDGFRβ. VEGFR inhibitors are known to cause cardiotoxicity. We sought to assess th...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0d73f957effbc672fd2f21b31fa74b7e
https://doi.org/10.1200/jco.2015.33.15_suppl.e15605

Zobrazit plný text záznamu

Dovitinib in first-line metastatic renal cell carcinoma and correlation of efficacy with tumor gene status: A phase II clinical trial

Autor: Paul Oei, Peter C.C. Fong, George Dranitsaris, Kerin Thompson, Steve Duffey, Fritha J. Hanning, Carol Fraser-Browne, Nicola Jane Mitchell, Mark J. McKeage, Reuben James Broom, Jonathan Zwi, Georgia Wilson

Publikováno v: Journal of Clinical Oncology. 32:4569-4569

4569 Background: Dovitinib is an anti-VEGFR tyrosine kinase inhibitor which also inhibits FGFR-1,-2,-3 and PDGFRβ. We studied its activity as 1st-line therapy in patients with metastatic clear-cell...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::639f03895a418e7fa1deb4590fc594e8
https://doi.org/10.1200/jco.2014.32.15_suppl.4569

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání